Tulex Pharmaceuticals — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Tulex Pharmaceuticals is a private, technology-focused CDMO and specialty pharma company established in 2014 (with a later corporate iteration in 2021). It combines proprietary drug delivery technology platforms, notably its GREAT and BEST systems, with end-to-end development and manufacturing services. The company targets the development of its own pipeline of complex oral drugs while also serving as a contract partner for emerging pharmaceutical companies, aiming to improve bioavailability and create differentiated, affordable therapeutics.

Drug Delivery

Technology Platform

Proprietary drug delivery platforms including the Gradient Release Enabling Technology (GREAT) Platform for controlled release and the Bioavailability Enhancement Sizing Technology (BEST) Platform for improving solubility and absorption of oral drugs.

Opportunities

The growing trend of outsourcing by biopharma companies, especially virtual and small biotechs, presents a significant opportunity for its integrated CDMO services.

Its proprietary drug delivery platforms offer the potential to create high-value, differentiated oral products that can be out-licensed to larger partners, providing substantial upside.

Risk Factors

The company faces intense competition from larger, well-capitalized CDMOs and drug delivery firms.

Its proprietary R&D carries high technical and regulatory risk, and its service revenue is vulnerable to fluctuations in biotech funding cycles and potential regulatory issues at its manufacturing facility.

Competitive Landscape

Tulex competes in the crowded CDMO market against large global players (e.g., Lonza, Catalent) and numerous niche providers. In drug delivery technology, it competes with specialized firms like Alkermes, Assertio, and many private platforms. Its differentiation lies in its integrated U.S. facility, proprietary oral delivery platforms, and expertise in complex formulations and controlled substances.

More companies in Drug Delivery & Formulation →More companies in United States →